92867 ⎘
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
Urease inhibiting composition and use of same
#2LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES
#3NEUTRAL LIPID AND LIPID NANOPARTICLE
#4COMPOSITIONS AND METHODS FOR TREATING CANCER
#5Olfactory Delivery Scaffolds Using Antisense Oligonucleotides and Methods for Making and Using Same
#6IONIZABLE LIPIDOID COMPOSITIONS AND THERAPEUTIC USES THEREOF
#7IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF
#8LIPIDIC COMPOUNDS, AND USES THEREOF
#9TARGETED COMPOSITIONS
#10FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES
#11LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
#12LIPID NANOMATERIALS AND USES THEREOF
#13TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS
#14LOCAL ANESTHETICS WITH SELECTIVE-SENSORY NERVE BLOCKADE
#15AMINO ACID DERIVATIVES AND THEIR USE AS FLAVOR MODIFIERS
#16AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF
#17CHIRAL MULTIDENTATE LIGAND, AND APPLICATION THEREOF IN ASYMMETRIC HYDROGENATION
#18Ionizable compounds and compositions and uses thereof
#19STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF
#20Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
#21High penetration drugs and their compositions thereof for treatment of Parkinson diseases
#22Anionic-cationic-nonionic surfactant, production and use thereof
#23Hydroxy-substituted amino and ammonium derivatives and their medical use
#24COMPOSITIONS AND METHODS FOR TREATING CANCER
#25N-(3-(2-(4-CHLOROPHENOXY)ACETAMIDO)BICYCLO[1.1.1] PENTAN-1-YL)-2-CYCLOBUTANE-1- CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR TREATING CANCER AND OTHER DISEASES
#26Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#27Cationic lipids for therapeutic agent delivery formulations
#28Derivatives of sobetirome
#29Lipids for therapeutic agent delivery formulations
#30Anionic-cationic-nonionic surfactant, production and use thereof
#31BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS
#32Compositions and methods for treating cancer
#33Hydroxy-substituted amino and ammonium derivatives and their medical use
#34Targeted nucleic acid conjugate compositions
#35Ionizable compounds and compositions and uses thereof
#36Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#37Nucleic acid-containing lipid nanoparticles
#38Monosubstituted or polysubstituted amphiphilic hypocrellin derivative, and preparation method and application thereof
#39Lipids and lipid compositions for the delivery of active agents
#40Cationic lipids for therapeutic agent delivery formulations
#41SHIP1 modulators and methods related thereto
#42Bicyclic aryl sphingosine 1-phosphate analogs
#43Derivatives of sobetirome
#44CATIONIC LIPID
#45High penetration drugs and their compositions thereof for treatment of Parkinson diseases
#46Anionic-cationic-nonionic surfactant, production and use thereof
#47Liquid-organic hydrogen carrier systems based on catalytic peptide formation and hydrogenation
#48Bicyclic aryl sphingosine 1-phosphate analogs
#49Hydroxy-substituted amino and ammonium derivatives and their medical use
#50Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanine
#51HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL
#52Process for the production of ralfinamide salts substantially free from impurities having genotoxic effects
#53SHIP1 modulators and methods related thereto
#54Derivatives of sobetirome
#55Methods and compositions for selective and targeted cancer therapy
#56Cationic lipids for therapeutic agent delivery formulations
#57Bicyclic aryl sphingosine 1-phosphate analogs
#58Lipids for therapeutic agent delivery formulations
#59Heterocyclic inhibitors of the sodium channel
#60High penetration drugs and their compositions thereof for treatment of parkinson diseases
#61Compositions and methods for the treatment of moderate to severe pain
#62Hydroxy-substituted amino and ammonium derivatives and their medical use
#63Dendrimer scaffolds for pharmaceutical use
#64Substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#65Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#66Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#67Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#68Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#69Aminoacid lipids
#70Bicyclic aryl sphingosine 1-phosphate analogs
#71Lipids and lipid compositions for the delivery of active agents
#72Nitric oxide donor compounds
#73Family of polyamine arylethylamide compounds, and their cosmetic or dermocosmetic use
#74Lipids for therapeutic agent delivery formulations
#75Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#76Chemosensory Receptor Ligand-Based Therapies
#77CATIONIC LIPID
#78Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#79Compounds and methods for treating candidiasis and aspergillus infections
#80Synthesis of trivalent flexible frameworks with ligands comprising catechol units for functionalizing surfaces
#81ROS-activated compounds as selective anti-cancer therapeutics
#82Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
#83Process for the production of ralfinamide salts substantially free from impurities having genotoxic effects
#84Cationic lipids for therapeutic agent delivery formulations
#85Heterocyclic CETP inhibitors
#86Compounds, pharmaceutical compositions and uses thereof
#87MEXILETINE PRODRUGS
#88Bicyclic aryl sphingosine 1-phosphate analogs
#89Glycine compound
#90Novel Therapeutic Compounds
#91NOVEL SUBSTITUTED ARYL DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES AS ANTI-HIV AGENTS
#92Class of cationic lipids for transporting active agents into cells
#93Substituted 2-aminoacetamides and the use thereof
#94Contrast agents endowed with high relaxivity
#95Processes for removal of dibenzofulvene
#96Probes, Systems, and Methods for Drug Discovery
#97MEXILETINE AMINO ACID AND PEPTIDE PRODRUGS AND USES THEREOF
#98High purity 2-[4-(3- OR 2-fluorobenzyloxy)benzylamino]propanamides and methods of use thereof
#99Reagent for introduction of protein or gene
#100Heterocyclic CETP inhibitors
#101Additives for fuel oils
#102Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
#103Pleuromutilin derivatives and their use as antimicrobials
#104OCULOSELECTIVE DRUGS AND PRODRUGS
#105Highly Branched Reagents For Modifying Biopharmaceuticals, Their Preparation And Use
#106Dendritic chelated compounds, methods for making the same and pharmaceutical compositions containing the same
#107NITRIC OXIDE DONOR COMPOUNDS
#108Fluorosurfactants
#109TYPE 1, 4-NAPHTOQUINONE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USE OF THESE COMPOUNDS AS ANTI-CANCER AGENTS
#110Substituted 2-aminoacetamides and the use thereof
#111Analogue compounds of archaebacterial membrane lipids and liposomal compounds integrating such compounds
#112Calcium receptor active compounds
#113GLYCEROL ESTER DERIVATIVE HAVING METAL CHELATE STRUCTURE
#114Prodrugs of propofol, compositions and uses thereof
#115Fluorescent Labeled Sphingosines
#116Bis-cationic compounds and use thereof
#117Benzyloxypropylamine derivative
#118Compounds for Treating Urinary Incontinence
#119Methods and compositions for modulating sphingosine -1- phosphate (S1P) receptor activity
#120Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents
#121Oculoselective Drugs and Prodrugs
#122β-Benzyloxyaspartate derivatives with amino group on benzene ring
#123N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
#124Heterocyclic CETP inhibitors
#125Process for the preparation of midodrine, pharmaceutically acceptable salts thereof and intermediates
#126Substituted amino acids as erythropoietin mimetics
#127Substituted 2-aminoacetamides and the use thereof
#128Tubulin binding agents and corresponding prodrug constructs
#129Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
#130Prodrugs of propofol, compositions and uses thereof
#131Oculoselective drugs and prodrugs
#132Hydroaminomethylation of olefins
#133Hair cosmetic, aminocarboxylic acid amide and method for producing the same
#134Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
#135Hair cosmetic, aminocarboxylic acid amide and method for producing the same